• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mereo BioPharma Group plc - American Depositary Shares (NQ:MREO)

0.4218 +0.0428 (+11.29%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Mereo BioPharma Group plc - American Depositary Shares

< Previous 1 2 Next >
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
January 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
December 30, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta
December 29, 2025
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights
November 10, 2025
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
September 02, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
August 29, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
August 25, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
August 21, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
August 17, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
August 13, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
August 12, 2025
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
August 09, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
August 05, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
August 01, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
July 28, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
July 23, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO
July 18, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
July 09, 2025
Data from Orbit and Cosmic studies expected around the end of the year 
From Ultragenyx Pharmaceutical Inc.
Via GlobeNewswire
News headline image
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights
May 13, 2025
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights
March 26, 2025
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference
March 05, 2025
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma Provides Update on Lead Clinical Programs
January 12, 2025
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference
November 14, 2024
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 12, 2024
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference
September 12, 2024
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 13, 2024
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
June 14, 2024
From Mereo BioPharma Group plc
Via GlobeNewswire
News headline image
Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)
June 11, 2024
From Ultragenyx Pharmaceutical Inc.
Via GlobeNewswire
News headline image
Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
May 30, 2024
From Mereo BioPharma Group plc
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap